We identify new therapeutic applications for existing pharmaceutical molecules, accelerating development timelines and reducing costs while maximizing patient benefit.
By leveraging established safety profiles and existing regulatory data, drug repurposing offers a faster, more cost-effective pathway to bringing new treatments to patients in need.
Coupled with AI assistance to reduce TATs.
Strategic approaches to unlock new therapeutic opportunities
Systematic screening and computational approaches to identify promising new indications for existing drugs.
Leverage existing safety data to accelerate clinical development and reduce time to market significantly.
Dramatically reduce development costs by utilizing established manufacturing and regulatory pathways.
